1. Academic Validation
  2. The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats

The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats

  • PLoS One. 2013 Oct 15;8(10):e77073. doi: 10.1371/journal.pone.0077073.
Mohamed Izikki 1 Olaf Mercier Florence Lecerf Lauriane Lubert Guin Eric Hoang Peter Dorfmüller Frédéric Perros Marc Humbert Gerald Simonneau Philippe Dartevelle Elie Fadel Saadia Eddahibi
Affiliations

Affiliation

  • 1 INSERM U999, Le Plessis-Robinson, France.
Abstract

Background: Pulmonary hypertension (PH) is a progressive disorder characterized by an increase in pulmonary artery pressure and structural changes in the pulmonary vasculature. Several observations indicate that growth factors play a key role in PH by modulating pulmonary artery smooth muscle cell (PA-SMC) function. In rats, established monocrotaline-induced PH (MCT-PH) can be reversed by blocking platelet-derived growth factor receptors (PDGF-R), epidermal growth factor receptors (EGF-R), or Fibroblast Growth Factor receptors (FGF-R). All these receptors belong to the receptor tyrosine kinase (RTK) family.

Methods and results: We evaluated whether RTK blockade by the nonspecific growth factor inhibitor, suramin, reversed advanced MCT-PH in rats via its effects on growth-factor signaling pathways. We found that suramin inhibited RTK and ERK1/2 phosphorylation in cultured human PA-SMCs. Suramin inhibited PA-SMC proliferation induced by serum, PDGF, FGF2, or EGF in vitro and ex vivo. Treatment with suramin from day 1 to day 21 after monocrotaline injection attenuated PH development, as shown by lower values for pulmonary artery pressure, right ventricular hypertrophy, and distal vessel muscularization on day 21 compared to control rats. Treatment with suramin from day 21 to day 42 after monocrotaline injection reversed established PH, thereby normalizing the pulmonary artery pressure values and vessel structure. Suramin treatment suppressed PA-SMC proliferation and attenuated both the inflammatory response and the deposition of collagen.

Conclusions: RTK blockade by suramin can prevent MCT-PH and reverse established MCT-PH in rats. This study suggests that an anti-RTK strategy that targets multiple RTKs could be useful in the treatment of pulmonary hypertension.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》